tradingkey.logo

U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio

ReutersDec 29, 2025 5:05 PM

- Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Expedia Group, Hasbro and Palisade Bio on Monday.

HIGHLIGHTS

Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300

Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90

Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating

Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507

Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts target price to $14.50 from $17

Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts to market perform from outperform

BP BP.N: Gerdes Energy Research cuts target price by $1 to $48

Citigroup C.N: Piper Sandler raises target price to $130 from $120

Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300

Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90

Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating

Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with price target $25

Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507

Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI